TW202327629A - 超高分子量聚合物及使用其之方法 - Google Patents

超高分子量聚合物及使用其之方法 Download PDF

Info

Publication number
TW202327629A
TW202327629A TW111132759A TW111132759A TW202327629A TW 202327629 A TW202327629 A TW 202327629A TW 111132759 A TW111132759 A TW 111132759A TW 111132759 A TW111132759 A TW 111132759A TW 202327629 A TW202327629 A TW 202327629A
Authority
TW
Taiwan
Prior art keywords
unit
water
soluble polymer
mucin
group
Prior art date
Application number
TW111132759A
Other languages
English (en)
Chinese (zh)
Inventor
布倫特 Ｓ 薩默林
庫倫 Ｌ Ｇ 戴維森
華萊士 Ｇ 索耶
胡安 Ｍ 烏拉諾亞瓦加斯
Original Assignee
美商佛羅里達大學研究基金會公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商佛羅里達大學研究基金會公司 filed Critical 美商佛羅里達大學研究基金會公司
Publication of TW202327629A publication Critical patent/TW202327629A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L33/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • C08L33/24—Homopolymers or copolymers of amides or imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6903—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being semi-solid, e.g. an ointment, a gel, a hydrogel or a solidifying gel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/52—Amides or imides
    • C08F220/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L43/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing boron, silicon, phosphorus, selenium, tellurium or a metal; Compositions of derivatives of such polymers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L53/00—Compositions of block copolymers containing at least one sequence of a polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Polyethers (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Graft Or Block Polymers (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Peptides Or Proteins (AREA)
TW111132759A 2021-08-31 2022-08-30 超高分子量聚合物及使用其之方法 TW202327629A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163239027P 2021-08-31 2021-08-31
US63/239,027 2021-08-31

Publications (1)

Publication Number Publication Date
TW202327629A true TW202327629A (zh) 2023-07-16

Family

ID=85385170

Family Applications (1)

Application Number Title Priority Date Filing Date
TW111132759A TW202327629A (zh) 2021-08-31 2022-08-30 超高分子量聚合物及使用其之方法

Country Status (10)

Country Link
US (1) US12624204B2 (enExample)
EP (1) EP4395791A4 (enExample)
JP (1) JP2024530714A (enExample)
KR (1) KR20240058883A (enExample)
CN (1) CN117999081A (enExample)
AU (1) AU2022339756A1 (enExample)
CA (1) CA3228099A1 (enExample)
MX (1) MX2024002537A (enExample)
TW (1) TW202327629A (enExample)
WO (1) WO2023034765A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250033149A (ko) * 2022-04-29 2025-03-07 유니버시티 오브 플로리다 리서치 파운데이션, 아이엔씨. 초-고분자량 폴리머 및 이를 제조하고 사용하는 방법
CN116333197A (zh) * 2023-04-12 2023-06-27 厦门君德医药科技有限公司 胃肠道粘膜性聚合物、组合物及制备方法和应用
WO2025250735A1 (en) * 2024-05-29 2025-12-04 University Of Florida Research Foundation, Inc. Compositions comprising synthetic mucins and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6649722B2 (en) 1999-12-10 2003-11-18 Novartis Ag Contact lens
US8071121B2 (en) 2002-06-05 2011-12-06 University Of Florida Research Foundation, Incorporated Dispersions of microemulsions in hydrogels for drug delivery
US7988988B2 (en) 2005-11-21 2011-08-02 Bausch & Lomb Incorporated Contact lenses with mucin affinity
US7832856B2 (en) * 2006-12-20 2010-11-16 Bausch & Lomb Incorporated Coatings and solutions for contact lenses
EP2364330B1 (en) 2008-11-06 2015-03-25 University Of Washington Multiblock copolymers
US8534031B2 (en) 2008-12-30 2013-09-17 Bausch & Lomb Incorporated Packaging solutions
US8410190B2 (en) 2009-09-22 2013-04-02 Coopervision International Holding Company, Lp Wettable hydrogel materials for use in ophthalmic applications and methods
US9452198B2 (en) * 2012-04-23 2016-09-27 Massachusetts Institute Of Technology Lectin conjugates for mucin hydration
US10196470B2 (en) 2016-05-16 2019-02-05 Benz Research And Development Corp. Hydrophobic intraocular lens
EP3852768A4 (en) * 2018-09-20 2022-09-14 Glyscend, Inc. BORONIC ACID POLYMERS AND METHODS OF USE
EP4066867B1 (en) * 2020-01-16 2023-12-06 Toray Industries, Inc. Method for producing medical device

Also Published As

Publication number Publication date
US12624204B2 (en) 2026-05-12
CN117999081A (zh) 2024-05-07
AU2022339756A1 (en) 2024-02-08
US20230076717A1 (en) 2023-03-09
KR20240058883A (ko) 2024-05-03
MX2024002537A (es) 2024-05-24
WO2023034765A3 (en) 2023-04-13
EP4395791A4 (en) 2025-06-25
WO2023034765A2 (en) 2023-03-09
JP2024530714A (ja) 2024-08-23
CA3228099A1 (en) 2023-03-09
EP4395791A2 (en) 2024-07-10

Similar Documents

Publication Publication Date Title
US12624204B2 (en) Ultra-high molecular weight polymers and methods of using the same
Liu et al. Ionic liquid functionalized non-releasing antibacterial hydrogel dressing coupled with electrical stimulation for the promotion of diabetic wound healing
JP6400666B2 (ja) 架橋した双性イオンヒドロゲル
Wang et al. Thermoresponsive self-healing zwitterionic hydrogel as an in situ gelling wound dressing for rapid wound healing
Peng et al. A pH and temperature dual-responsive microgel-embedded, adhesive, and tough hydrogel for drug delivery and wound healing
Wang et al. Injectable, self-healing hydrogel with tunable optical, mechanical, and antimicrobial properties
Banerjee et al. A self-healable and antifouling hydrogel based on PDMS centered ABA tri-block copolymer polymersomes: a potential material for therapeutic contact lenses
Jerca et al. Poly (2-isopropenyl-2-oxazoline) hydrogels for biomedical applications
Chen et al. In situ forming ROS-scavenging hybrid hydrogel loaded with polydopamine-modified fullerene nanocomposites for promoting skin wound healing
Horvát et al. Thiolated poly (aspartic acid) as potential in situ gelling, ocular mucoadhesive drug delivery system
Zhang et al. Antifouling and antibacterial zwitterionic hydrogels as soft contact lens against ocular bacterial infections
Eskandarinia et al. Antibacterial self-healing bilayer dressing for epidermal sensors and accelerate wound repair
JP2011504526A (ja) 制御された生物学的特性を有する双性イオン性ベタインへのカチオン性ベタイン前駆体
CN110431203B (zh) 经离子改性的有机硅、组合物和由其形成的医疗器材
Yang et al. Recent advances in fabricating injectable hydrogels via tunable molecular interactions for bio-applications
Liu et al. A tough Janus hydrogel patch with strong wet adhesion and self-debonding for oral ulcer treatment
Liu et al. A highly stretchable, adhesive, anti-freezing hydrogel with prominent antibacterial property rapidly prepared by photopolymerization for wound dressing
Tang et al. Bioinspired by sandcastle worm glue: An underwater reversible adhesive modulated by pH environments based on urushiol
Luan et al. Bioactive cellulose-based thermoresponsive hydrogel with engineered ordered channels for rapid hemostasis and tissue regeneration
CA3180428A1 (en) In situ gelling zwitterionic hydrogel compositions, and methods of use thereof
US9421164B2 (en) Stimuli responsive adhesive gel for removal of foreign particles from soft tissue
Harvey et al. Antimicrobial graft copolymer gels
Wang et al. Self-generating electricity system driven by aqueous humor flow and trabecular meshwork contraction motion activated BCKa for glaucoma intraocular pressure treatment
Guerron et al. Multiresponsive microgels: Toward an independent tuning of swelling and surface properties
TWI908439B (zh) 雙面異質性高分子人工水晶體、其製備方法及用於抗貼附、抗細胞遷移、抗發炎及抗後囊混濁的用途